247 related articles for article (PubMed ID: 21466969)
1. [Technological evolutions in blood donation screening and their impact on the residual risk].
Barlet V
Transfus Clin Biol; 2011 Apr; 18(2):292-301. PubMed ID: 21466969
[TBL] [Abstract][Full Text] [Related]
2. [Ten years of nucleic acid testing: lessons and prospects].
Morel P
Transfus Clin Biol; 2011 Apr; 18(2):133-9. PubMed ID: 21397544
[TBL] [Abstract][Full Text] [Related]
3. Fifteen years of Nucleic Acid Testing in France: Results and lessons.
Laperche S; Tiberghien P; Roche-Longin C; Pillonel J
Transfus Clin Biol; 2017 Sep; 24(3):182-188. PubMed ID: 28709845
[TBL] [Abstract][Full Text] [Related]
4. Genomic screening for blood-borne viruses in transfusion settings.
Lee HH; Allain JP
Vox Sang; 1998; 74 Suppl 2():119-23. PubMed ID: 9704433
[No Abstract] [Full Text] [Related]
5. [Controlled viral risks].
Barin F
Transfus Clin Biol; 2000 Feb; 7(1):24-9. PubMed ID: 10730343
[TBL] [Abstract][Full Text] [Related]
6. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
Pillonel J; Laperche S; ; ;
Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
[TBL] [Abstract][Full Text] [Related]
7. The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors.
Rocha D; Andrade E; Godoy DT; Fontana-Maurell M; Costa E; Ribeiro M; Ferreira AGP; Brindeiro R; Tanuri A; Alvarez P
Transfusion; 2018 Apr; 58(4):862-870. PubMed ID: 29383720
[TBL] [Abstract][Full Text] [Related]
8. A pilot study on screening blood donors with individual-donation nucleic acid testing in China.
Dong J; Wu Y; Zhu H; Li G; Lv M; Wu D; Li X; Zhu F; Lv H
Blood Transfus; 2014 Apr; 12(2):172-9. PubMed ID: 24333061
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.
Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; David B; De Micco P
Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230
[TBL] [Abstract][Full Text] [Related]
10. [Viruses and unconventional transmissible agents: update on transmission via blood ].
Barin F
Transfus Clin Biol; 2000 Jun; 7 Suppl 1():5s-10s. PubMed ID: 10919217
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
[TBL] [Abstract][Full Text] [Related]
12. The potential of viral metagenomics in blood transfusion safety.
Sauvage V; Gomez J; Boizeau L; Laperche S
Transfus Clin Biol; 2017 Sep; 24(3):218-222. PubMed ID: 28694025
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
Hourfar MK; Schmidt M; Seifried E; Roth WK
Vox Sang; 2005 Aug; 89(2):71-6. PubMed ID: 16101686
[TBL] [Abstract][Full Text] [Related]
14. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
15. Yield and future issues of nucleic acid testing.
Roth WK; Seifried E
Transfus Clin Biol; 2001 Jun; 8(3):282-4. PubMed ID: 11499978
[TBL] [Abstract][Full Text] [Related]
16. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays.
Kretzschmar E; Chudy M; Nübling CM; Ross RS; Kruse F; Trobisch H
Vox Sang; 2007 May; 92(4):297-301. PubMed ID: 17456153
[TBL] [Abstract][Full Text] [Related]
17. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
18. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
Bruhn R; Lelie N; Busch M; Kleinman S;
Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of a transfusion emergent risk: the case of HEV].
Pillonel J; Gallian P; Sommen C; Couturier E; Piquet Y; Djoudi R; Laperche S;
Transfus Clin Biol; 2014 Nov; 21(4-5):162-6. PubMed ID: 25267205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
